Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Committee approves patient‑assistance reporting amendment for drug transparency bill and sends bill to floor
Summary
The Senate Committee adopted a dash-2 amendment to SB 1528 to require drug manufacturers to report details of all patient assistance programs for Oregon consumers and forwarded the bill to the Senate floor with a due‑pass recommendation.
The Senate Committee on Health Care on Feb. 16 approved a dash-2 amendment to Senate Bill 1528 requiring drug manufacturers to report annually on all patient assistance programs, and recommended the amended bill to the Senate floor.
Under the adopted amendment, manufacturers must report information including the number of Oregon consumers who participated, eligibility criteria and the…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
